Curium Announces ECLIPSE Trial Has Met Primary Endpoint, Demonstrating a Statistically Significant and Clinically Meaningful Benefit for Patients With PSMA-Positive Metastatic Castration Resistant Prostate Cancer 13-11-2024, 22:57

IBN’s Bell2Bell Podcast Releases 100th Episode 31-01-2023, 19:19

VCI Global Expands AI Footprint with US$33 Million in AI Infrastructure Contracts Across Three Enterprises 24-03-2025, 19:33